Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota-Reference-Cited by-同舟云学术

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

Published:2018-01-23 Issue:4 Volume:118 Page:471-479
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Goedert James J,Hua Xing,Bielecka Agata,Okayasu Isao,Milne Ginger L,Jones Gieira S,Fujiwara Mutsunori,Sinha Rashmi,Wan Yunhu,Xu Xia,Ravel Jacques,Shi Jianxin,Palm Noah W,Feigelson Heather Spencer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017435.pdf

Reference45 articles.

1. Adlercreutz H, Martin F (1980) Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 13 (2): 231–244.

2. Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR (2011) Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 126 (1): 149–155.

3. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8 (1): 42.

4. Bowers LW, Brenner AJ, Hursting SD, Tekmal RR, deGraffenried LA (2015) Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production. Breast Cancer Res Treat 149 (1): 49–57.

5. Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, Price RS, Tekmal RR, Jolly CA, deGraffenried LA (2014) NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res 74 (16): 4446–4457.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacomicrobiomics in precision cancer therapy: bench to bedside;Frontiers in Immunology;2024-09-09

2. Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy;Frontiers in Immunology;2024-08-26

3. The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer;Frontiers in Cellular and Infection Microbiology;2024-07-05

4. Guideline for designing microbiome studies in neoplastic diseases;GeroScience;2024-06-26

5. Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy;Clinical and Translational Oncology;2024-06-18